Ex-Receptos CTO co-founds SD startup Escient, launching with $40M Series A
After the whopping $7.2 billion sale of his last venture, Receptos, to Celgene back in 2015, Marcus Boehm wasn’t supposed to start another company. He was going to take a backseat, for once. Consult. Be on a few boards.
“I’ve been involved in three companies since founding stages, and I was not intending to do this again,” Boehm tells me.
Now, he and another biotech big shot in San Diego are joining forces to launch a rather ambitious startup, stepping out Wednesday with a $40 million Series A round.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.